bimzelx
Generic: bimekizumab
Labeler: ucb, inc.Drug Facts
Product Profile
Brand Name
bimzelx
Generic Name
bimekizumab
Labeler
ucb, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
bimekizumab 160 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
50474-780
Product ID
50474-780_37b310bd-f6a0-9d4e-e063-6294a90a889d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761151
Listing Expiration
2026-12-31
Marketing Start
2023-10-17
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50474780
Hyphenated Format
50474-780
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bimzelx (source: ndc)
Generic Name
bimekizumab (source: ndc)
Application Number
BLA761151 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 160 mg/mL
Packaging
- 1 SYRINGE, GLASS in 1 CARTON (50474-780-78) / 1 mL in 1 SYRINGE, GLASS
- 2 SYRINGE, GLASS in 1 CARTON (50474-780-79) / 1 mL in 1 SYRINGE, GLASS
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "37b310bd-f6a0-9d4e-e063-6294a90a889d", "openfda": {"unii": ["09495UIM6V"], "rxcui": ["2668086", "2668093", "2668099", "2668103", "2699121", "2699122", "2699123", "2699124"], "spl_set_id": ["26b88358-871f-4c80-9d80-b2fb16477f81"], "manufacturer_name": ["UCB, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (50474-780-78) / 1 mL in 1 SYRINGE, GLASS", "package_ndc": "50474-780-78", "marketing_start_date": "20241001"}, {"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (50474-780-79) / 1 mL in 1 SYRINGE, GLASS", "package_ndc": "50474-780-79", "marketing_start_date": "20231017"}], "brand_name": "Bimzelx", "product_id": "50474-780_37b310bd-f6a0-9d4e-e063-6294a90a889d", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "50474-780", "generic_name": "bimekizumab", "labeler_name": "UCB, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bimzelx", "active_ingredients": [{"name": "BIMEKIZUMAB", "strength": "160 mg/mL"}], "application_number": "BLA761151", "marketing_category": "BLA", "marketing_start_date": "20231017", "listing_expiration_date": "20261231"}